THERAPEUTIC MOLECULES | VARIABLES | PERIOD | P-VALUE | |
| Intraocular pressure (mmHg) | At diagnosis | After one year of treatment |
|
Beta-blockers | RIGHT EYE | 20.9 ± 5.08 | 17.9 ± 5.28 | <0.001 |
LEFT EYE | 21.6 ± 5.34 | 18.0 ± 4.89 | <0.001 | |
Prostaglandin agonists | RIGHT EYE | 23.0 ± 4.88 | 18.0 ± 2.96 | 0.007 |
LEFT EYE | 23.9 ± 7.20 | 17.8 ± 3.66 | 0.019 | |
Carbonic anhydrase inhibitors | RIGHT EYE | 32.0 ± 2.40 | 19.2 ± 0.35 | 0.590 |
LEFT EYE | 24.5 ± 6.36 | 26.5 ± 2.12 | 0.736 | |
Beta-blockers + Carbonic anhydrase inhibitors | RIGHT EYE | 28.3 ± 10.9 | 18.9 ± 6.57 | <0.001 |
LEFT EYE | 33.9 ± 11.5 | 20.8 ± 8.70 | <0.001 | |
Beta-blockers + Prostaglandin agonists | RIGHT EYE | 23.8 ± 9.10 | 17.2 ± 3.79 | 0.002 |
LEFT EYE | 23.6 ± 7.01 | 17.9 ± 7.08 | 0.005 | |
Carbonic anhydrase inhibitors + Prostaglandin agonists | RIGHT EYE | 35.5 ± 9.19 | 16.0 ± 1.41 | 0.198 |
LEFT EYE | 23.0 ± 7.07 | 14.2 ± 1.63 | 0.316 | |
Beta-blockers + Carbonic anhydrase inhibitors + Prostaglandin agonists | RIGHT EYE | 37.1 ± 12.6 | 22.8 ± 11.7 | 0.101 |
LEFT EYE | 39.5 ± 14.7 | 24.1 ± 12.3 | 0.112 |